Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q4 2026 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2025 Net Income$59.53K$59.53Kderived+34.2% vs Q4 2025 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$931— Operating Incomederived-$38,910N/M Operating Cash Flowderived$9,401N/M ended May 31, 2026 · filed Sep 25, 2026 · 117 d after period end